Samyang, Takeda to join forces in DDS platform technology
Published: 2011-04-18 06:57:00
Updated: 2011-04-18 06:57:00
Samyang Corp. and Takeda Pharmaceutical have agreed to join hands to discover a novel DDS platform technology for RNAi therapeutics. Samyang has biopolymer technology that is considered to serve as a platform for novel DDS technology.
To this end, both companies signed an agreement to form a r...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
